| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.16 | $2.60 | $2.42 | $2.66 | $3.12 | $0.88 | $0.53 | $0.63 |
| EPS (Diluted) | $3.13 | $2.58 | $2.41 | $2.64 | $3.11 | $0.88 | $0.53 | $0.63 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $8.1B | $7.8B | $7.2B | $7.1B | $6.3B | $5.4B | $5.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.5B | $7.2B | $6.9B | $6.4B | $6.3B | $5.6B | $4.7B | $4.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.9B | $0.8B | $0.8B | $0.8B | $0.7B | $0.7B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.1B | $-0.3B | $-0.5B | $-0.9B | $-0.1B | $-0.9B | $-0.3B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $0.3B | $0.5B | $0.1B | $0.7B | $0.9B | $0.3B | $0.4B |